OCUL
Ocular Therapeutix, Inc.
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$8.55
+$0.04
(+0.47%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $1.82B | EPS (ttm) | $-1.43 | Current Price | $8.55 |
| Enterprise Value | $1.55B | Forward EPS | $-1.48 | Previous Close | $8.51 |
| P/E Ratio | - | ROA | -36.61% | 52W High | $16.44 |
| Forward P/E | -5.78 | ROE | -81.83% | 52W Low | $5.79 |
| PEG Ratio | - | Gross Margin | -246.87% | 50 Day Avg | $12.01 |
| P/S Ratio | 32.65 | Operating Margin | -472.35% | 200 Day Avg | $10.91 |
| P/B Ratio | 5.79 | Profit Margin | - | Volume | 6.69M |
| EV/EBITDA | -5.95 | Current Ratio | 7.85 | Avg Volume | 3.95M |
| EV/Sales | 27.70 | Quick Ratio | 7.62 | Beta | 0.90 |
| Employees | 274.00 | Debt/Equity | 29.82 | Shares Outstanding | 213.05M |
| Sector | Healthcare | Total Debt | $77.01M | Float Shares | 186.13M |
| Industry | Biotechnology | Total Cash | $344.77M | Short Float | 6.02% |
| Optionable | Yes | Cash/Share | $1.62 | Short Ratio | 2.92 |
| Dividend Yield | - | Book Value/Share | $1.48 | % Held by Insiders | 2.88% |
| Target Price | $24.25 | Revenue (TTM) | $55.78M | % Held by Institutions | 90.42% |